Determinants of drug prices and expenditures

William S. Comanor and Stuart O. Schweitzer
Additional contact information
William S. Comanor: Professor of Health Services, UCLA School of Public Health and Professor of Economics, Postal: Professor of Health Services, UCLA School of Public Health and Professor of Economics
Stuart O. Schweitzer: Professor of Health Services, UCLA School of Public Health, Postal: Professor of Health Services, UCLA School of Public Health

Health Economics, 2007, vol. 28, issue 4-5, pages 357-370

Abstract: The process by which pharmaceuticals are bought and sold is exceedingly complex. The major reason is that most consumers do not pay directly for the drugs they consume. Intermediaries are generally present who purchase pharmaceuticals from their manufacturers and have them provided to their subscribers or affiliates. The products themselves, however, are generally supplied by the same pharmacies used by cash purchasers. The purpose of this paper is to describe and examine these markets. Copyright © 2007 John Wiley & Sons, Ltd.

Date: 2007
View list of references

Downloads: (external link)
http://hdl.handle.net/10.1002/mde.1346 Link to full text; subscription required (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: http://EconPapers.repec.org/RePEc:wly:hlthec:v:28:y:2007:i:4-5:p:357-370

Access Statistics for this article

Health Economics is edited by Alan Maynard, John Hutton and Andrew Jones

More articles in Health Economics from John Wiley & Sons, Ltd.
Series data maintained by Christopher F. Baum ().